Lv1
10 积分 2023-05-26 加入
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
1天前
已完结
273P A preoperative window-of-opportunity (WOO) study of imlunestrant in ER+, HER2- early breast cancer (EBC): Final analysis from EMBER-2
1天前
已完结
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
1天前
已完结
383MO Imlunestrant with or without everolimus or alpelisib, in ER+, HER2- advanced breast cancer (aBC): Results from the phase Ia/b EMBER study
2天前
已完结
395P Interim analysis (IA) of the giredestrant (G) + ipatasertib (IPAT) arm in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC)
2天前
已完结
354TiP A phase III randomised open-label study of extended adjuvant therapy with camizestrant vs standard endocrine therapy (ET) in patients with ER+/HER2– early breast cancer (BC) and an intermediate or high risk of recurrence (CAMBRIA-1)
2天前
已完结
382MO Updated results from the phase I/II study of OP-1250, an oral complete estrogen receptor (ER) antagonist (CERAN) and selective ER degrader (SERD) in patients (pts) with advanced or metastatic ER-positive, HER2-negative breast cancer
2天前
已完结
Estrogen receptors alpha and beta expression in different canine cancer types with an emphasis on hematopoietic malignancies
3天前
已完结
Expression of estrogen receptor (ER) α and β during recrudescence of spermatogenesis following downregulation using a slow release GnRH agonist implant in the dog
3天前
已完结
皖公网安备34019202002308
